Comparing vasopressin and norepinephrine for treating low blood pressure after heart surgery
Official title: Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery
Run by University of Sao Paulo · NCT06934798 · Data updated 2026-11-12
This study is testing whether vasopressin or norepinephrine works better to treat low blood pressure in patients who develop complications after heart surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | University of Sao Paulo Academic / other |
| Locations | 1 site (São Paulo) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | July 30, 2025 |
| Study ends | July 30, 2025 |
| Registry record updated | April 30, 2025 |
| Trial ID | NCT06934798 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 undergoing coronary artery bypass grafting or valve surgery who develop vasoplegic syndrome within 24 hours postoperatively.
✕Probably not a fit
Patients who have undergone aortic surgery, heart transplants, or emergency surgeries, or those with certain postoperative complications, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is a randomized, double-blind investigation comparing the effects of vasopressin versus norepinephrine in patients who develop vasoplegic syndrome shortly after cardiac surgery. Vasoplegic syndrome leads to severe low blood pressure despite adequate fluid resuscitation, and this study aims to determine which vasopressor is more effective in improving cardiac output and hemodynamic stability. Eligible patients will receive either vasopressin or norepinephrine, with their responses monitored through various echocardiographic and hemodynamic parameters. The findings could help refine treatment protocols for managing this serious postoperative complication.
Why it matters
Potential benefit: If successful, this study could lead to improved management of vasoplegic syndrome, enhancing patient outcomes after cardiac surgery.
How similar studies have gone: While norepinephrine is the standard treatment, the exploration of vasopressin as an alternative is relatively novel, and previous studies have shown mixed results regarding its efficacy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18. * Patients undergoing coronary artery bypass grafting, valve surgery or both, with a diagnosis of vasoplegic syndrome in the immediate postoperative period (\<24 hours), defined as mean arterial pressure \< 65 mmHg (measured using an invasive blood pressure catheter) and resistance to fluid replacement - at least 1000ml of crystalloids. Exclusion Criteria: * Pregnancy or breastfeeding. * Aortic surgery. * Surgeries to correct congenital heart disease. * Heart transplants. * Emergency surgery. * Use of vasopressor therapy in the preoperative period. * Presence of a ventricular assist device other than an intra-aortic balloon in the postoperative period. * Severe hyponatremia in the postoperative period (serum sodium less than 130mEq/l). * Postoperative acute coronary syndrome. * Mesenteric ischemia in the postoperative period. * History of Raynaud's disease. * History of neoplasia.
Where it's running
-
Instituto do Coração HCFMUSP
São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Ludhmila A Hajjar, Full Professor — University of Sao Paulo
- Study coordinator: José León
- Email: aro@incor.usp.br
- Phone: +55 (11) 2661-5795
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Monitoring small- and large-vessel blood flow during heart surgery in patients at risk of vasoplegic syndrome
We will test whether adding earlobe and palm skin sensors plus clinical and blood measurements during and for 48 hours after heart surgery helps understand and predict vasoplegic syndrome in patients at higher risk.
-
HPA (stress hormone) function in adults who develop vasoplegia after cardiac surgery
This project will test whether the body's stress-hormone system (the HPA axis and cortisol response) is altered in adults who develop vasoplegic syndrome after heart surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.